Observational studyMedicine2025
Efficacy of TiRobot assistance in distal locking for femoral intramedullary nailing.
Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study compares the efficacy of the TiRobot with traditional external aiming frames in distal locking of femoral intramedullary nails. A cohort of 44 patients, who underwent intramedullary nailing treatment for femoral fractures between October 2020 and October 2023, was retrospectively analyzed. Participants were allocated into 2 groups. The observation group (n = 22) received TiRobot assistance for distal locking of femoral intramedullary nails, and the control group (n = 22) was managed using conventional external aiming frames. Key variables included the first-attempt success rate of distal locking, number of fluoroscopic exposures, time to achieve locking, and volume of intraoperative blood loss. The observation group, assisted by TiRobot, achieved a significantly higher first-attempt success rate of 90.9%, as compared to 54.5% in the control group. All initial failures were subsequently managed manually, with a statistically significant difference noted between the groups (P < .05). Furthermore, the observation group required fewer fluoroscopic exposures (11.00 ± 2.93) than the control group (19.68 ± 16.28) (P < .05). The time to achieve locking was significantly shorter in the observation group (14.05 ± 3.37 min) compared to the control group (24.41 ± 14.93 min) (P < .05). The volume of intraoperative blood loss was reduced in the observation group (54.55 ± 5.54 mL) versus the control group (60.45 ± 11.01 mL) (P < .05). The incorporation of TiRobot in the distal locking of femoral intramedullary nailing prominently enhances the first-attempt success rate, reduces the procedural time and intraoperative blood loss, and diminishes the radiation exposure for both healthcare providers and patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.